The interaction of PD-L1 on tumor cells and PD-1 on activated T cells similarly limits the anti-tumor capacity of endogenous tumor-reactive T cells and adoptively transferred T cells, including TRuC and CAR T cells [8]. The gene discussed is CD274; the disease is neoplasm.